ALK and lung cancer: Fusion between EML4 (echinoderm microtubule associated protein-like 4), a microtubule-associated protein, and ALK (anaplastic lymphoma kinase), a tyrosine kinase receptor belonging to the insulin receptor superfamily, was the first oncogenic fusion to be detected in lung cancer [7].